Advertisement
Research Article Free access | 10.1172/JCI114653
Laboratoire d'Immunologie UA1156, Institut Gustave Roussy, Villejuif, France.
Find articles by Blay, J. in: JCI | PubMed | Google Scholar
Laboratoire d'Immunologie UA1156, Institut Gustave Roussy, Villejuif, France.
Find articles by Branellec, D. in: JCI | PubMed | Google Scholar
Laboratoire d'Immunologie UA1156, Institut Gustave Roussy, Villejuif, France.
Find articles by Robinet, E. in: JCI | PubMed | Google Scholar
Laboratoire d'Immunologie UA1156, Institut Gustave Roussy, Villejuif, France.
Find articles by Dugas, B. in: JCI | PubMed | Google Scholar
Laboratoire d'Immunologie UA1156, Institut Gustave Roussy, Villejuif, France.
Find articles by Gay, F. in: JCI | PubMed | Google Scholar
Laboratoire d'Immunologie UA1156, Institut Gustave Roussy, Villejuif, France.
Find articles by Chouaïb, S. in: JCI | PubMed | Google Scholar
Published June 1, 1990 - More info
In previous studies, IL-4 has been reported to interfere with IL-2-driven generation of lymphokine-activated killer (LAK) activity. In this investigation, we have demonstrated that IL-4 inhibited the IL-2-induced differentiation of large granular lymphocytes (LGL) into LAK effectors by a mechanism involving, at least in part, an increase in LGL intracellular cAMP levels. In contrast, with its capacity to induce cAMP accumulation in resting LGL, IL-4 had a very negligible effect on LAK activity induction, and cAMP levels increase in LGL that had been preincubated with IL-2. Furthermore, the inhibitory effect of IL-4 on LAK activity generation also correlated with a marked decrease in N-CBZ-L-lysine thiobenzylester esterase activity, with an inhibition of tumor necrosis factor (TNF) mRNA expression and TNF production by IL-2-stimulated LGL. These results strongly suggest that complex signaling processes could be ascribed to the dual activities of cytokines and their interplay in LAK promotion.
Images.